Hao Qin

2.3k total citations · 3 hit papers
34 papers, 1.9k citations indexed

About

Hao Qin is a scholar working on Oncology, Biomedical Engineering and Molecular Biology. According to data from OpenAlex, Hao Qin has authored 34 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Biomedical Engineering and 8 papers in Molecular Biology. Recurrent topics in Hao Qin's work include Nanoplatforms for cancer theranostics (9 papers), Peptidase Inhibition and Analysis (5 papers) and Immunotherapy and Immune Responses (5 papers). Hao Qin is often cited by papers focused on Nanoplatforms for cancer theranostics (9 papers), Peptidase Inhibition and Analysis (5 papers) and Immunotherapy and Immune Responses (5 papers). Hao Qin collaborates with scholars based in China, Australia and Iran. Hao Qin's co-authors include Guangjun Nie, Ruifang Zhao, Ying Zhao, Jian Shi, Xuexiang Han, Yinlong Zhang, Jiayan Lang, Keman Cheng, Gregory J. Anderson and Yuting Qin and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Hao Qin

32 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology

2021 359 citations Keman Cheng, Ruifang Zhao et al. Nature Communications profile →
Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines

2021 186 citations Long Chen, Hao Qin et al. Science Translational Medicine profile →
Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis

2024 72 citations Ronghui Deng, Ruifang Zhao et al. Science Translational Medicine profile →

Peers

Countries citing papers authored by Hao Qin

Since Specialization

Citations

This map shows the geographic impact of Hao Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Qin more than expected).

Fields of papers citing papers by Hao Qin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Qin. The network helps show where Hao Qin may publish in the future.

Co-authorship network of co-authors of Hao Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Qin. A scholar is included among the top collaborators of Hao Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Qin. Hao Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer 2025 ·Journal of Experimental & Clinical Cancer Research ·Mingxing Xie, Hao Qin, Liu Li, Jing Wu, (unknown), Yaodong Zhao, (unknown), Xin Yu, (unknown)	11
2	Chondrocyte membrane–coated nanoparticles promote drug retention and halt cartilage damage in rat and canine osteoarthritis breakdown → 2024 ·Science Translational Medicine ·Ronghui Deng, Ruifang Zhao, Zining Zhang, Yang Chen, Meng Yang, Yixuan Lin, Jing Ye, Nan Li, Hao Qin, Xin Yan, Jian Shi, Fuzhen Yuan, (unknown), Zijie Xu, Yifan Song, (unknown), Bingbing Xu, Guangjun Nie, Jia‐Kuo Yu	72
3	Neurosurgical clipping versus endovascular coiling for patients with ruptured anterior circulation aneurysms: A systematic review and meta-analysis 2024 ·Neurosurgical Review ·(unknown), Hao Qin, Jiahao Liu, (unknown), Xiaolong Wang, Li Han, Xinmin Ding	3
4	Beyond Cumulative Scores: Distinct Patterns of Adverse Childhood Experiences and Their Differential Impact on Emotion, Borderline Personality Traits, and Executive Function 2024 ·Stress and Health ·(unknown), (unknown), Man Li, (unknown), Hao Qin, Jing Liu, Weiwen Wang	0
5	Correction to: Neurosurgical clipping versus endovascular coiling for patients with ruptured anterior circulation aneurysms: A systematic review and meta‑analysis 2024 ·Neurosurgical Review ·(unknown), Hao Qin, Jiahao Liu, (unknown), Xiaolong Wang, Li Han, (unknown)	1
6	Targeted delivery of liposomal senolytics to alleviate cellular senescence-induced bone loss 2024 ·Fundamental Research ·Rong Li, Yaohua Wei, Chuanxi Xiong, Jingwei Wang, Yixuan Lin, Ronghui Deng, Hao Qin, Chen Yang, Nan Li, Guoguang Zheng, Yuanyuan Lv, Jian Shi, Tingting Yu, Yiye Li, Jing Wang, Ruifang Zhao, Changsheng Liu, Guangjun Nie	1
7	Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine 2024 ·Cell Reports Medicine ·Yang Chen, Hao Qin, Nan Li, Yaohua Wei, Yixuan Lin, Ronghui Deng, Hao Ding, Yuanyuan Lv, Tianyu Ma, Rong Li, Chuanxi Xiong, Guoguang Zheng, Hanqing Chen, Jian Shi, Yuliang Zhao, Ruifang Zhao, Guangjun Nie	6
8	Biosynthesized gold nanoparticles that activate Toll-like receptors and elicit localized light-converting hyperthermia for pleiotropic tumor immunoregulation 2023 ·Nature Communications ·Hao Qin, (unknown), (unknown), Nan Li, Qing Sun, Yixuan Lin, (unknown), Yuting Qin, Long Chen, Hanqing Chen, Yiye Li, Jian Shi, Guangjun Nie, Ruifang Zhao	26
9	Biogenetic Vesicle‐Based Cancer Vaccines with Tunable Surface Potential and Immune Potency 2023 ·Small ·Hao Qin, (unknown), Jin Zhu, Yuting Qin, Nan Li, Jian Shi, Guangjun Nie, Ruifang Zhao	13
10	META analysis on the effect of taijiquan on improving negative psychological symptoms of college students and the optimal dose 2022 ·Frontiers in Public Health ·(unknown), (unknown), Hao Qin, Ruiqi Wang, (unknown), Xiao-Nan Yao	10
11	Incidence of coronary drug-eluting stent fracture: A systematic review and meta-analysis 2022 ·Frontiers in Cardiovascular Medicine ·Yang Chen, Dandan Li, Yanhui Liao, (unknown), (unknown), (unknown), (unknown), (unknown), Hao Qin, (unknown), (unknown), Longlong Hu, Renqiang Yang	4
12	Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines breakdown → 2021 ·Science Translational Medicine ·Long Chen, Hao Qin, Ruifang Zhao, Xiao Zhao, (unknown), Yang Chen, Yixuan Lin, Yao Li, Yuting Qin, Yiye Li, Shaoli Liu, Keman Cheng, Hanqing Chen, Jian Shi, Gregory J. Anderson, Yan Wu, Yuliang Zhao, Guangjun Nie	186
13	Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology breakdown → 2021 ·Nature Communications ·Keman Cheng, Ruifang Zhao, Yao Li, Yingqiu Qi, Yazhou Wang, Yinlong Zhang, Hao Qin, Yuting Qin, Long Chen, Chen Li, Jie Liang, Yujing Li, Jiaqi Xu, Xuexiang Han, Gregory J. Anderson, Jian Shi, Lei Ren, Xiao Zhao, Guangjun Nie	359
14	Personal Neoantigens From Patients With NSCLC Induce Efficient Antitumor Responses 2021 ·Frontiers in Oncology ·Wei Zhang, Qi Yin, Haidong Huang, Jingjing Lu, Hao Qin, Si Chen, Wenjun Zhang, Xiaoping Su, (unknown), Yuchao Dong, Qiang Li	16
15	Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth 2019 ·ACS Nano ·Jiayan Lang, Xiao Zhao, Xiuchao Wang, Ying Zhao, Yiye Li, Ruifang Zhao, Keman Cheng, Yao Li, Xuexiang Han, Xiaowei Zheng, Hao Qin, (unknown), Jian Shi, Gregory J. Anderson, Jihui Hao, He Ren, Guangjun Nie	54
16	Precision design of nanomedicines to restore gemcitabine chemosensitivity for personalized pancreatic ductal adenocarcinoma treatment 2017 ·Biomaterials ·Xiao Zhao, Xiuchao Wang, Wei Sun, Keman Cheng, Hao Qin, Xuexiang Han, Yu Lin, Yongwei Wang, Jiayan Lang, Ruifang Zhao, Xiaowei Zheng, Ying Zhao, Jian Shi, Jihui Hao, Qing Miao, Guangjun Nie, He Ren	31
17	Tumor Microenvironment Targeting and Responsive Peptide-Based Nanoformulations for Improved Tumor Therapy 2017 ·Molecular Pharmacology ·Hao Qin, Yanping Ding, Ayeesha Mujeeb, Ying Zhao, Guangjun Nie	55
18	Inhibition of platelet function using liposomal nanoparticles blocks tumor metastasis 2017 ·Theranostics ·Yinlong Zhang, Jingyan Wei, Shaoli Liu, Jing Wang, Xuexiang Han, Hao Qin, Jiayan Lang, Keman Cheng, Yiye Li, Yingqiu Qi, Gregory J. Anderson, Saraswati Sukumar, Suping Li, Guangjun Nie	78
19	Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation 2015 ·Angewandte Chemie ·Tianjiao Ji, Ying Zhao, Yanping Ding, Jing Wang, Ruifang Zhao, Jiayan Lang, Hao Qin, (unknown), Jian Shi, Tao Ning, Zhihai Qin, Guangjun Nie, Yuliang Zhao	26
20	Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer‐Associated Fibroblast Activation 2015 ·Angewandte Chemie International Edition ·Tianjiao Ji, Ying Zhao, (unknown), Yanping Ding, Jing Wang, Ruifang Zhao, Jiayan Lang, Hao Qin, Xiaoman Liu, Jian Shi, Tao Ning, Zhihai Qin, Guangjun Nie, Yuliang Zhao	185

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact